Evidence map›Paper›PMID 30546894›Full record

ArticleMolecular and clinical oncology2018

Thymidine phosphorylase affects clinical outcome following surgery and mRNA expression levels of four key enzymes for 5-fluorouracil metabolism in patients with stage I and II non-small cell lung cancer.

Naoya Himuro, Yumiko Niiya, Takao Minakata, Yutaka Oshima, Daisuke Kataoka, Shigeru Yamamoto, Takashi Suzuki, Mitsutaka Kadokura

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular and clinical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Naoya HimuroDivision of Chest Surgery, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Yumiko NiiyaDivision of Chest Surgery, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Takao MinakataDivision of Chest Surgery, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Yutaka OshimaDivision of Chest Surgery, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Daisuke KataokaDivision of Chest Surgery, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Shigeru YamamotoDivision of Chest Surgery, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Takashi SuzukiDivision of Chest Surgery, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Mitsutaka KadokuraDivision of Chest Surgery, Department of Surgery, Showa University School of Medicine, Tokyo 142-8666, Japan.
Showa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression levels of thymidine phosphorylase (

Indexed as

complete resectionDanenberg tumor profile methodnon-small-cell lung cancerprognostic factorthymidine phosphorylase

Identifiers

PMID30546894
PMCPMC6256090
OpenAlexW2892965374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.